Saturday, March 1, 2025
8:00AM – 9:00AM: Breakfast Snack / Learning Gallery
9:00AM -12:00PM: Continental Breakfast / Meeting
12:00PM – 1:00PM: Lunch / Learning Gallery
Renaissance Atlanta Midtown Hotel
866 W Peachtree St NW
Atlanta, GA 30308
Meeting Room – Highball Ballroom
PROGRAM FEATURES
-
- Downloadable whiteboard animations
- Interactive, case-based learning environment
- Create-your-own personalized poster
PRESENTING FACULTY
 |
Jay H. Shubrook, DO, FAAFP, FACOFP Professor and Diabetologist Department of Clinical Sciences and Community Health Touro University California Vallejo, CA |
 |
Elaine M. Apperson, MD Chief, Division of Pediatric Endocrinology, Prisma Health-Upstate Associate Professor, University of South Carolina School of Medicine-Greenville Attending Physician, Prisma Health Children’s Hospital-Upstate Greenville, NC |
PATIENT CAREGIVER
Kimberly Belz
Lafayette, CO
PROGRAM OVERVIEW
The DETECT T1D Live Summit series has been designed to bring together a multidisciplinary care team and a patient to discuss practical considerations in screening, follow-up, early referral, and treatment to prevent T1D progression, as well as how to address both clinician and patient challenges to optimize early identification and patient selection. In addition, this program will include a moderator to reinforce engagement and dive deeper on the recent advances, such as the release of the consensus monitoring guidance, criteria for teplizumab use guidance & practical considerations, as well as a more detailed discussion on emerging approaches for new onset (stage 3) T1D.
PRELIMINARY AGENDA
8:00 AM – 9:00 AM • Learning Gallery and Networking Reception
During the networking reception, we will provide attendees with an opportunity to network with our
speaking faculty, while enjoying an Immersive Learning Gallery Experience, that includes a number of engaging and interactive learning stations with the following components:
- A virtual reality lounge, utilizing Oculus Headsets, with stunning VR 360 animations on optimal patient and physician interactions
- Interactive Augmented Reality Headsets, where learners can manipulate their virtual environment to learn about T1D screening and diagnosis, in an exciting way
- Create your own clinical practice poster and personalize it with your name and practice
View our DETECT1D Website through touchscreens and get a tour of all of the free tools and resources for clinician and patient education - Manage life-sized interactive holographic AI patients Emma (pediatric/adolescent) and Mike (adult) where you can ask them questions and make real-time treatment decisions based on the patient’s responses
These engaging learning and networking opportunities with top thought leaders are offered before and after the
live program to maximize your connections and knowledge to offer your patients the best chance to achieve optimal outcomes.
9:00 AM – 12:00 PM • Breakfast and CME Presentation
This interactive live presentation has been designed to bring together a multidisciplinary care team with a patient to discuss practical considerations in screening, follow-up, early referral, and treatment to prevent T1D progression, as well as how to best address clinician and patient challenges to optimize early identification and patient selection. In addition, this program features a moderator to reinforce engagement and encourage a deeper dive into recent advances. Program focus includes the latest consensus guidance for monitoring T1d, criteria, guidance, and practical considerations for teplizumab use, and a detailed discussion on emerging approaches for new onset (stage 3) T1D.
12:00 PM – 1:00 PM • Learning Gallery and Lunch
Continuation of networking session, with an opportunity to engage with our expert faculty speakers and avail of the interactive learning stations described above.
TARGET AUDIENCE
This activity is designed to meet the educational needs of Pediatric and Adult Endocrinologists, Pediatricians, Primary Care Providers, Endocrine Nurses, and other healthcare professionals involved in the care of patients with T1D.
LEARNING OBJECTIVES
Upon completion of this activity, attendees will have improved ability to:
- Describe the clinical presentation of T1D in adults compared to children
- Identify appropriate autoantibody screening strategies for T1D, including type, frequency, and number
- Interpret results from screening protocols to drive management decisions
- Discuss the latest clinical evidence for efficacy and tolerability of newly approved and investigational immunomodulatory agents
- Implement strategies for appropriate clinical monitoring and early screening in individuals at highest risk
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 3.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of up to 3.5 ANCC contact hours.
COMMISSION ON DIETETIC REGISTRATION (CDR) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 3.5 CPEU.
PHARMACISTS AND PHARMACY TECHNICIANS (ACPE) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of up to 3.5 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event Staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to the live event at [email protected]
